← Back to Search

Omega-3 Fatty Acid Supplement

1 for Insulin Resistance

Phase 1
Waitlist Available
Led By Debra A. Krummel, PhD, RD
Research Sponsored by National Heart, Lung, and Blood Institute (NHLBI)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at approximately month 3
Awards & highlights

Study Summary

Women with excess adiposity while pregnant are more likely to develop gestational diabetes and high blood pressure during pregnancy than women of healthy weights. This may occur because overweight and obese pregnant women are less sensitive to insulin and have more inflammation than pregnant women of healthy weights. This study will examine the effect of a nutritional supplement, docosahexaenoic acid (DHA), on improving insulin sensitivity and lessening inflammation in overweight and obese pregnant women.

Eligible Conditions
  • Insulin Resistance
  • Obesity
  • Gestational Diabetes
  • Hypertension
  • Pre-eclampsia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at approximately month 3
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at approximately month 3 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Insulin sensitivity
Secondary outcome measures
Interleukin-6 (IL-6)

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: 1Active Control1 Intervention
Participants will receive DHA supplements.
Group II: 2Placebo Group1 Intervention
Participants will receive placebo capsules of corn oil.

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)Lead Sponsor
3,837 Previous Clinical Trials
47,851,537 Total Patients Enrolled
47 Trials studying Insulin Resistance
11,495 Patients Enrolled for Insulin Resistance
Office of Research on Women's Health (ORWH)NIH
32 Previous Clinical Trials
36,021 Total Patients Enrolled
Mead Johnson NutritionIndustry Sponsor
79 Previous Clinical Trials
16,278 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
DHA Supplements to Improve Insulin Sensitivity in Obese Pregnant Women (The Omega-3 Pregnancy Study)
2009. "DHA Supplements to Improve Insulin Sensitivity in Obese Pregnant Women (The Omega-3 Pregnancy Study)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00865683.
All > Pregnancy
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top